L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found

Read more

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Read more

Study reveals a small molecule inhibits SARS-CoV-2 infection in cells

Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral

Read more

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Rotavirus is a common diarrheal disease that affects young children. Live oral rotavirus vaccines have been used to reduce its

Read more

A glycan controls how SARS-CoV-2’s spike protein opens, study finds

Using simulations, a team of researchers in the U.S. found that the glycan at position N343 of the severe acute

Read more

SARS-CoV-2 D614G mutation associated with lower antibody binding

The onset of the coronavirus disease 2019 (COVID-19) pandemic has brought about an international effort to uncover the biology of

Read more

China's SARS and SARS-CoV-2 outbreak management in comparative perspective

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic – caused by the severe acute respiratory syndrome coronavirus 2

Read more